Public Profile

Camurus

Camurus AB, a pioneering biopharmaceutical company headquartered in Sweden, focuses on developing innovative medicines for patients with severe and chronic conditions. Founded in 2016, Camurus has rapidly established itself in the pharmaceutical industry, particularly in the fields of pain management and addiction treatment. The company is renowned for its proprietary FluidCrystal® technology, which enables the formulation of long-acting injectable therapies. This unique approach enhances patient compliance and treatment outcomes. Camurus has achieved significant milestones, including the successful launch of its lead product, Buvidal®, for opioid dependence, positioning itself as a leader in the market. With a strong presence in Europe and expanding operations globally, Camurus continues to make strides in improving patient care through its advanced therapeutic solutions.

DitchCarbon Score

How does Camurus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

31

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Camurus's score of 31 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

86%

Camurus's reported carbon emissions

In 2023, Camurus reported total carbon emissions of approximately 561,800 kg CO2e, a significant increase from about 231,600 kg CO2e in 2022. The emissions breakdown for 2023 includes Scope 1 emissions of about 158,900 kg CO2e, primarily from mobile combustion, which accounted for approximately 150,350 kg CO2e. Scope 2 emissions totalled about 11,680 kg CO2e, while Scope 3 emissions were notably high at approximately 385,600 kg CO2e, with downstream transportation and distribution contributing about 287,714 kg CO2e. Despite the increase in total emissions, Camurus has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company operates from its headquarters in Sweden (SE) and is committed to addressing climate change, although further details on their climate commitments or strategies are not available.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
162,400
000,000
Scope 2
8,990
00,000
Scope 3
60,300
000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Camurus's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Camurus is headquartered in SE, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Camurus is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Abeona Therapeutics Inc.

US
Health and social work services (85)
Updated 14 days ago

Td Medtekhnologii, Ooo

RU
Food products nec
Updated 21 days ago

Jazz Pharmaceuticals (EUSA Pharma USA) Inc.

US
Health and social work services (85)
Updated about 1 month ago
DitchCarbon Score

Fortovia Therapeutics, Inc.

US
Health and social work services (85)
Updated about 1 month ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers